Amlodipine + Valsartan

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Hypertension

Conditions

Hypertension

Trial Timeline

Dec 1, 2016 โ†’ Jan 6, 2020

About Amlodipine + Valsartan

Amlodipine + Valsartan is a approved stage product being developed by Yuhan for Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT02973035. Target conditions include Hypertension.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT02973035ApprovedCompleted

Competing Products

20 competing products in Hypertension

See all competitors
ProductCompanyStageHype Score
macitentan 10 mgBML, Inc.Phase 3
76
tadalafil + tadalafilEli LillyPhase 3
77
CS1 AdministrationCereno ScientificPhase 2
47
CS1Cereno ScientificPre-clinical
18
TX000045- Dose A + TX000045- Dose B + PlaceboTectonic TherapeuticPhase 2
44
Dose A KER-012 + Dose B KER-012 + Dose C KER-012 + Placebo for 24 Weeks followed by Dose B KER-012 for 72 weeksKeros TherapeuticsPhase 2
44
Tirzepatide + Tirzepatide PlaceboEli LillyApproved
85
L04RD1 + L04TD3CelltrionPhase 1
33
Azilsartan MedoxomilCelltrionPre-clinical
23
AZM X mg + AML Y mg + AZM X mg + AML Y' mg + AZM X' mg + AML Y mg + AZM X' mg + AML Y' mg + AZM X mg + AZM X' mg + AML Y mg + AML Y' mgCelltrionPhase 3
77
Satralizumab (Genetical Recombination)Chugai PharmaceuticalPhase 2
52
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgYuhanApproved
85
Telmisartan + Amlodipine + ChlorthalidoneYuhanPhase 1
33
Temisartan/Amlodipine+Rosuvastatin + YHP1604YuhanPhase 1
33
Temisartan+Amlodipine+Rosuvastatin (Combination drug) + Temisartan+Amlodipine + Temisartan+RosuvastatinYuhanPhase 3
77
Duowellยฎ + TelmisartanYuhanApproved
85
YHP1701 + YHR1703 + YHR1704YuhanPhase 3
77
YH22189 + Twynsta 80/10mg + Crestor 20mgYuhanPhase 1
33
OM 40 + OM/HCTZ 40/12.5Daiichi SankyoPhase 3
77
Rosuvastatin+Valsartan (Sequence 1) + Rosuvastatin+Valsartan (Sequence 2) + Rosuvastatin+Valsartan (Sequence 3) + Rosuvastatin+Valsartan (Sequence 4) + Rosuvastatin+Valsartan (Sequence 5) + Rosuvastatin+Valsartan (Sequence 6)YuhanPhase 1
33